Report: Are VCs fleeing med-tech?
October 7, 2011 by MassDevice staff
Investors move away from medical devices and into areas less regulated by the FDA, National Venture Capitalists Assn. survey finds.
Investors are paring their stakes in health care and shifting capital into projects with less regulatory risk, according to a new survey by the National Venture Capitalists Assn.'s Medical Innovation & Competitiveness Coalition.
Investors are running away from med-tech and pharma in particular, with 61 of the VCs pointing to regulatory challenges as the prime reason for the shift, the survey found.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
Navigation
NEWS
Covidien touts positive study data from Barrx ablation system
Covidien champions positive results for the Barrett's esophagus ablation device it acquired along...
Abbott touts CE Mark for "world's longest" coronary DES
Illinois healthcare giant Abbott lands European regulatory approval for the Xience Xpedition 48,...
ALung pursues Chinese approval for Hemolung
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist...
Legal: Patient's lawyer says Intuitive Surgical's training is all about "control"
An attorney for a plaintiff suing robot-assisted surgical systems maker Intuitive Surgical says the...
Can a smartphone help spot a stroke? | MassDevice.com On Call
The American Stroke Assn. and partners release the Spot a Stroke F.A.S.T. smartphone app to help...
